Elisabeth Mahase is an award-winning health journalist at The BMJ, where she specializes in translating complex medical research into actionable insights for healthcare professionals. With a background in biomedical science and science communication, her work focuses on three core areas:
"Journalism is something you can learn through persistent effort - it's not some innate talent."
We've followed Elisabeth Mahase's evolution from biomedical researcher to one of the UK's most respected health journalists with keen interest. Her career demonstrates how scientific rigor combined with narrative skill can create impactful medical journalism.
"Trade magazines are the best place to learn. You are given time to develop, a defined readership to focus on, and in my case a lot of guidance." - Mahase on early career development
This 2025 investigation into AI medical devices combines policy analysis with clinical impact assessments. Mahase interviewed 23 stakeholders across regulatory bodies, NHS trusts, and AI developers to map the challenges of implementing machine learning tools in frontline care. The piece notably exposed disparities in validation testing between private healthcare systems and public NHS implementations.
Published at the height of the Delta variant surge, this article broke down complex genomic surveillance processes for general medical audiences. Mahase's ability to explain phylogenetic analysis through hospital case studies helped clinicians understand variant tracking methodologies.
This 2020 analysis of early pandemic data became a key reference for public health communications. By contextualizing age-stratified mortality rates with comorbidity factors, Mahase provided clinicians with tools to discuss risk assessment during vaccine rollout planning.
Mahase consistently explores how new technologies intersect with existing care pathways. A recent pitch success involved a deep dive into blockchain-based medical records trials across London ICUs. PR professionals should highlight real-world implementation hurdles rather than pure technical specifications.
Her analysis of adaptive trial designs during COVID-19 vaccine development (BMJ 2021) demonstrates interest in methodological advancements. Case studies featuring novel patient recruitment strategies or decentralized trial models align well with her beat.
Mahase's AI regulation article explicitly examined how algorithms might exacerbate care disparities. Successful pitches frame technological or policy developments through health equity lenses, particularly regarding NHS resource allocation.
At PressContact, we aim to help you discover the most relevant journalists for your PR efforts. If you're looking to pitch to more journalists who write on Health, here are some other real estate journalist profiles you may find relevant:
